# XYNOMIC PHARMACEUTICALS HOLDINGS, INC. — Form D

XYNOMIC PHARMACEUTICALS HOLDINGS, INC. of SHANGHAI, F4, a company, filed a Form D exempt-offering notice with the SEC on 2019-07-15. The offering totals $15.0M. Industry: Pharmaceuticals.

## Offering

- Filed: 2019-07-15
- Form: D
- Accession: 0001213900-19-012652
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $15.0M
- Remaining: $15.0M
- Minimum investment: $10K
- Security types: equity
- Revenue range: Not Applicable
- SEC file number: 021-344248

## Issuer

- Name: XYNOMIC PHARMACEUTICALS HOLDINGS, INC.
- CIK: 0001697805
- Entity type: Corporation
- Jurisdiction: VIRGIN ISLANDS, BRITISH
- Incorporated: 2016
- Address: 1010 MIDDLE HUAIHAI ROAD, SHANGHAI, F4, 200031
- Phone: +86 21 54180212

## Officers, directors & promoters (11)

| Name | Role | Location |
| --- | --- | --- |
| Thomas Coco Folinsbee | Director | Shanghai, F4 |
| Adam Richard Inglis | Director | Shanghai, F4 |
| Charles Vincent Prizzi | Director | Shanghai, F4 |
| Tingzhi Jason Qian | Director | Shanghai, F4 |
| Jiayuan James Tong | Director | Shanghai, F4 |
| Peidong Richard Wu | Director | Shanghai, F4 |
| Yinglin Mark Xu | Director | Shanghai, F4 |
| Jinwei Coco Kou | Executive Officer | Shanghai, F4 |
| Jiayuan James Tong | Executive Officer | Shanghai, F4 |
| Wentao Jason Wu | Executive Officer | Shanghai, F4 |
| Yinglin Mark Xu | Executive Officer | Shanghai, F4 |

## More

- [CIK 1697805 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1697805&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001213900-19-012652.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.